JP2015537212A - イオン強度媒介のｐｈ勾配イオン交換クロマトグラフィー - Google Patents

イオン強度媒介のｐｈ勾配イオン交換クロマトグラフィー Download PDF

Info

Publication number
JP2015537212A
JP2015537212A JP2015542849A JP2015542849A JP2015537212A JP 2015537212 A JP2015537212 A JP 2015537212A JP 2015542849 A JP2015542849 A JP 2015542849A JP 2015542849 A JP2015542849 A JP 2015542849A JP 2015537212 A JP2015537212 A JP 2015537212A
Authority
JP
Japan
Prior art keywords
polypeptide
gradient
antibody
ionic strength
contaminants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015542849A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015537212A5 (OSRAM
Inventor
ヤーチュン ワン，
ヤーチュン ワン，
ジョージ ティー． モレノ，
ジョージ ティー． モレノ，
ボヤン チャン，
ボヤン チャン，
リャンイー チャン，
リャンイー チャン，
デル ファーナン，
デル ファーナン，
トム パータポフ，
トム パータポフ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of JP2015537212A publication Critical patent/JP2015537212A/ja
Publication of JP2015537212A5 publication Critical patent/JP2015537212A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/96—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2015542849A 2012-11-15 2013-11-15 イオン強度媒介のｐｈ勾配イオン交換クロマトグラフィー Pending JP2015537212A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261727051P 2012-11-15 2012-11-15
US61/727,051 2012-11-15
US201361780707P 2013-03-13 2013-03-13
US61/780,707 2013-03-13
PCT/US2013/070415 WO2014078729A1 (en) 2012-11-15 2013-11-15 IONIC STRENGTH-MEDIATED pH GRADIENT ION EXCHANGE CHROMATOGRAPHY

Publications (2)

Publication Number Publication Date
JP2015537212A true JP2015537212A (ja) 2015-12-24
JP2015537212A5 JP2015537212A5 (OSRAM) 2016-12-28

Family

ID=50731733

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015542849A Pending JP2015537212A (ja) 2012-11-15 2013-11-15 イオン強度媒介のｐｈ勾配イオン交換クロマトグラフィー

Country Status (11)

Country Link
US (2) US9810670B2 (OSRAM)
EP (1) EP2920586A4 (OSRAM)
JP (1) JP2015537212A (OSRAM)
KR (1) KR20150084046A (OSRAM)
CN (1) CN105051528A (OSRAM)
BR (1) BR112015011011A2 (OSRAM)
CA (1) CA2890979A1 (OSRAM)
HK (1) HK1217232A1 (OSRAM)
MX (1) MX2015006149A (OSRAM)
RU (1) RU2015122726A (OSRAM)
WO (1) WO2014078729A1 (OSRAM)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2021210662A1 (OSRAM) * 2020-04-17 2021-10-21
JP2022547203A (ja) * 2019-09-25 2022-11-10 エフ．ホフマン－ラ ロシュ アーゲー 予測される溶出緩衝液の塩濃度を使用するカチオンクロマトグラフィー

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014078729A1 (en) 2012-11-15 2014-05-22 Genentech, Inc. IONIC STRENGTH-MEDIATED pH GRADIENT ION EXCHANGE CHROMATOGRAPHY
EP3019516B1 (en) * 2013-07-12 2018-11-14 H. Hoffnabb-La Roche Ag Elucidation of ion exchange chromatography input optimization
WO2016164708A1 (en) 2015-04-10 2016-10-13 Adimab, Llc Methods for purifying heterodimeric multispecific antibodies from parental homodimeric antibody species
GB2539420B (en) * 2015-06-16 2021-01-13 Cytiva Sweden Ab Determination of chromatography conditions
RU2018121653A (ru) * 2015-11-18 2019-12-19 Мерк Патент Гмбх Улучшенное разделение белков при ионообменной хроматографии
US20180346510A1 (en) * 2015-11-18 2018-12-06 Merck Patent Gmbh Opposite ph-salt gradients for improved protein separations
CN108333264A (zh) * 2017-01-20 2018-07-27 湖北生物医药产业技术研究院有限公司 检测蛋白电荷变异体的方法及确定生物制品生产工艺的方法
US20190126241A1 (en) * 2017-09-26 2019-05-02 Waters Technologies Corporation High purity chromatographic materials comprising an ionizable modifier for retention of acidic analytes
CN112105927B (zh) * 2018-05-08 2024-06-25 沃特世科技公司 可用于pH梯度阳离子交换色谱法的方法、组合物和试剂盒
KR20200080748A (ko) * 2018-12-27 2020-07-07 주식회사 폴루스 음이온 교환 크로마토그래피를 이용한 인슐린 전구체의 정제방법
CN111024883B (zh) * 2019-12-31 2022-12-06 上海博威生物医药有限公司 一种奥马珠单抗的电荷异质体的分离方法
CN111239278B (zh) * 2020-02-05 2022-11-04 康立泰生物医药(青岛)有限公司 一种检测重组人白介素-12蛋白电荷变异体的方法及应用
KR102283871B1 (ko) * 2021-03-02 2021-08-02 한국원자력연구원 크로마토그래피를 이용한 무담체 홀뮴-166의 분리 방법, 분리 장치 및 이에 의하여 분리된 무담체 홀뮴-166
AU2022309872A1 (en) * 2021-07-13 2024-01-25 Regeneron Pharmaceuticals, Inc. Characterization of proteins by anion-exchange chromatography mass spectrometry (aex-ms)
WO2023107510A1 (en) * 2021-12-06 2023-06-15 Staveness Daryl Exciplex-based methods for contaminant and disease detection and methods for use of extraction buffers
CN114544839B (zh) * 2022-01-20 2024-08-20 未名生物医药有限公司 一种抗人神经生长因子抗体的电荷变异体检测方法
EP4637838A1 (en) * 2022-12-20 2025-10-29 Seqirus Inc. Lipid nanoparticle composition
WO2024261724A1 (en) * 2023-06-23 2024-12-26 Lupin Limited Ion-exchange chromatography for separation and analysis of charge variants
WO2025038736A1 (en) * 2023-08-15 2025-02-20 Gigagen, Inc. Methods of analyzing recombinant polyclonal proteins

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055203A1 (en) * 1999-03-15 2000-09-21 Novo Nordisk A/S Ion exchange chromatographic separation of glp-1 and related peptides
US20060240564A1 (en) * 2005-04-20 2006-10-26 Chia-Hui Shieh pH gradient ion exchange LC-MS and mass compatible buffers
WO2007075283A2 (en) * 2005-12-06 2007-07-05 Amgen Inc. Polishing steps used in multi-step protein purification processes
JP2008511337A (ja) * 2004-09-02 2008-04-17 ジェネンテック・インコーポレーテッド ヘテロ多量体分子
JP2010510963A (ja) * 2006-06-14 2010-04-08 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー セラミックヒドロキシアパタイトを使用する抗体の精製方法
WO2011037983A1 (en) * 2009-09-23 2011-03-31 Medarex, Inc. Cation exchange chromatography
WO2012084829A1 (en) * 2010-12-21 2012-06-28 F. Hoffmann-La Roche Ag Isoform enriched antibody preparation and method for obtaining it
JP2013500244A (ja) * 2009-07-24 2013-01-07 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 抗体製造の最適化

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
DE3850542T2 (de) 1987-09-23 1994-11-24 Bristol Myers Squibb Co Antikörper-Heterokonjugate zur Töting von HIV-infizierten Zellen.
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
AU641673B2 (en) 1989-06-29 1993-09-30 Medarex, Inc. Bispecific reagents for aids therapy
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
US5356788A (en) * 1990-03-14 1994-10-18 Her Majesty The Queen In Right Of Canada, As Represented By The National Research Council Of Canada Isolation, quantitation and purification of insecticidal proteins from Bacillus thuringiensis
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
JPH06507398A (ja) 1991-05-14 1994-08-25 リプリジェン　コーポレーション Ｈｉｖ感染治療のための異種複合抗体
DE122004000008I1 (de) 1991-06-14 2005-06-09 Genentech Inc Humanisierter Heregulin Antikörper.
IE922437A1 (en) 1991-07-25 1993-01-27 Idec Pharma Corp Recombinant antibodies for human therapy
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
FI941572A7 (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenete lmä
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
EP1136556B1 (en) 1991-11-25 2005-06-08 Enzon, Inc. Method of producing multivalent antigen-binding proteins
JPH08500962A (ja) 1992-02-06 1996-02-06 クリエイティブ バイオモレキュルズ，インコーポレイテッド 癌マーカー用生物合成結合蛋白質
EP0626012B1 (en) 1992-02-11 2003-07-09 Cell Genesys, Inc. Homogenotization of gene-targeting events
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
ATE149570T1 (de) 1992-08-17 1997-03-15 Genentech Inc Bispezifische immunoadhesine
EP1005870B1 (en) 1992-11-13 2009-01-21 Biogen Idec Inc. Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5712374A (en) 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
WO2002047705A2 (en) * 2000-12-13 2002-06-20 Wackvom Limited Compositions containing an active fraction isolated from tricholoma conglobatum and methods of use
US8372954B2 (en) 2000-12-22 2013-02-12 National Research Council Of Canada Phage display libraries of human VH fragments
US20030031627A1 (en) * 2001-07-31 2003-02-13 Mallinckrodt Inc. Internal image antibodies for optical imaging and therapy
JP2005289809A (ja) 2001-10-24 2005-10-20 Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) 突然変異重鎖抗体
EP1601697B1 (en) * 2003-02-28 2007-05-30 Lonza Biologics plc Antibody purification by Protein A and ion exchange chromatography
DK1639011T3 (da) 2003-06-30 2009-02-16 Domantis Ltd Pegylerede enkelt-domæne antistoffer (dAb)
SE0303532D0 (sv) * 2003-12-23 2003-12-23 Amersham Biosciences Ab Purification of immunoglobulins
CN101023101A (zh) * 2004-07-20 2007-08-22 西福根有限公司 抗－恒河猴d重组多克隆抗体和生产方法
ZA200701715B (en) 2004-08-19 2008-07-30 Genentech Inc Polypeptide variants with altered effector function
TR201808537T4 (tr) 2004-09-23 2018-07-23 Genentech Inc Sistein değiştirilmiş antikorlar ve konjugatlar.
CN100506983C (zh) * 2006-05-25 2009-07-01 齐鲁制药有限公司 一种从矛头蝮蛇毒中提取单一成份巴曲酶的方法
CN101960307B (zh) * 2008-02-29 2015-01-21 积水医疗株式会社 高分子量脂联素的测定方法
BR112013019975A2 (pt) 2011-02-28 2017-08-01 Hoffmann La Roche proteínas de ligação de antígeno, composição farmacêutica, uso de uma proteína de ligação de antígeno, método para o tratamento de um paciente e método para a preparação de uma proteína de ligação de antígeno, ácido nucleico, vetor e célula hospedeira"
US9442050B2 (en) * 2012-02-14 2016-09-13 Bio-Rad Laboratories, Inc. Reducing pH excursions in ion exchange chromatography using displacing counter ions
WO2014078729A1 (en) 2012-11-15 2014-05-22 Genentech, Inc. IONIC STRENGTH-MEDIATED pH GRADIENT ION EXCHANGE CHROMATOGRAPHY

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055203A1 (en) * 1999-03-15 2000-09-21 Novo Nordisk A/S Ion exchange chromatographic separation of glp-1 and related peptides
JP2008511337A (ja) * 2004-09-02 2008-04-17 ジェネンテック・インコーポレーテッド ヘテロ多量体分子
US20060240564A1 (en) * 2005-04-20 2006-10-26 Chia-Hui Shieh pH gradient ion exchange LC-MS and mass compatible buffers
WO2007075283A2 (en) * 2005-12-06 2007-07-05 Amgen Inc. Polishing steps used in multi-step protein purification processes
JP2010510963A (ja) * 2006-06-14 2010-04-08 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー セラミックヒドロキシアパタイトを使用する抗体の精製方法
JP2013500244A (ja) * 2009-07-24 2013-01-07 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 抗体製造の最適化
WO2011037983A1 (en) * 2009-09-23 2011-03-31 Medarex, Inc. Cation exchange chromatography
WO2012084829A1 (en) * 2010-12-21 2012-06-28 F. Hoffmann-La Roche Ag Isoform enriched antibody preparation and method for obtaining it

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
"Continuous pH/Salt Gradient and Peptide Score for Strong Cation Exchange Chromatography in 2D-Nano-L", ANALYTICAL CHEMISTRY, JPN6017023412, 11 May 2005 (2005-05-11), pages 4991 - 4998, ISSN: 0003594772 *
"Isoprotein analysis by ion-exchange chromatography using a linear pH gradient combined with a salt g", JOURNAL OF CHROMATOGRAPHY, JPN6017023400, 4 June 1993 (1993-06-04), pages 41 - 49, ISSN: 0003752604 *
"Multiproduct High-Resolution Monoclonal Antibody Charge Variant Separations by pH Gradient Ion-Excha", ANALYTICAL CHEMISTRY, JPN6017023406, 31 August 2009 (2009-08-31), pages 8846 - 8857, ISSN: 0003752607 *
"Purification of ascitic fluid-derived murine monoclonal antibodies by anion-exchange and size exclus", JOURNAL OF CHROMATOGRAPHY, JPN6017023403, 7 April 1988 (1988-04-07), pages 329 - 339, ISSN: 0003752606 *
"Selection of pH-related parameters in ion-exchange chromatography using pH-gradient operations", JOURNAL OF CHROMATOGRAPHY, JPN6017023409, 8 December 2007 (2007-12-08), pages 22 - 29, ISSN: 0003752608 *
"Separation of manganese peroxidase isoenzymes on strong anion-exchange monolithic column using pH -s", JOURNAL OF CHROMATOGRAPHY, JPN6017023402, 27 October 2003 (2003-10-27), pages 343 - 347, ISSN: 0003752605 *
"Validation of a pH gradient-based ion-exchange chromatography method for high-resolution monoclonal", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, JPN6017023415, 21 August 2010 (2010-08-21), pages 317 - 323, ISSN: 0003594773 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022547203A (ja) * 2019-09-25 2022-11-10 エフ．ホフマン－ラ ロシュ アーゲー 予測される溶出緩衝液の塩濃度を使用するカチオンクロマトグラフィー
JP7598929B2 (ja) 2019-09-25 2024-12-12 エフ． ホフマン－ラ ロシュ アーゲー 予測される溶出緩衝液の塩濃度を使用するカチオンクロマトグラフィー
JPWO2021210662A1 (OSRAM) * 2020-04-17 2021-10-21
WO2021210662A1 (ja) * 2020-04-17 2021-10-21 小野薬品工業株式会社 タンパク質製剤原薬の着色除去方法
JP7686180B2 (ja) 2020-04-17 2025-06-02 小野薬品工業株式会社 タンパク質製剤原薬の着色除去方法

Also Published As

Publication number Publication date
CN105051528A (zh) 2015-11-11
WO2014078729A1 (en) 2014-05-22
HK1217232A1 (zh) 2016-12-30
US9810670B2 (en) 2017-11-07
KR20150084046A (ko) 2015-07-21
US10712322B2 (en) 2020-07-14
RU2015122726A (ru) 2017-01-10
MX2015006149A (es) 2015-08-05
US20180120273A1 (en) 2018-05-03
EP2920586A4 (en) 2017-01-04
EP2920586A1 (en) 2015-09-23
CA2890979A1 (en) 2014-05-22
BR112015011011A2 (pt) 2019-12-17
US20150285771A1 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
US10712322B2 (en) Ionic strength-mediated pH gradient ion exchange chromatography
JP6356607B2 (ja) オーバーロード／溶出クロマトグラフィー
JP6602765B2 (ja) クロマトグラフィー再使用のための方法
AU2022291517B2 (en) Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide
US10921297B2 (en) Elucidation of ion exchange chromatography input optimization
HK1222183B (zh) 阐明离子交换层析输入优化
HK40007967B (en) Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide
HK40007967A (en) Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161111

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161111

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170608

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170711

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180306